Laryngeal Papillomatosis.

Area of Science:

• Otolaryngology
• Virology
• Oncology

Background:

• Laryngeal papillomatosis, also known as recurrent respiratory papillomatosis (RRP), is the most common benign laryngeal disease.
• It is caused by the human papillomavirus (HPV).
• Juvenile-onset RRP typically exhibits more aggressive disease progression than adult-onset RRP.

Purpose of the Study:

• To review the current understanding and management of laryngeal papillomatosis.
• To highlight the challenges in treating recurrent respiratory papillomatosis.
• To discuss emerging therapeutic strategies for RRP.

Main Methods:

• Literature review of studies on laryngeal papillomatosis and recurrent respiratory papillomatosis.
• Analysis of current surgical and medical treatment modalities.
• Examination of ongoing research into novel therapies and vaccines.

Main Results:

• Recurrent respiratory papillomatosis requires frequent surgical interventions.
• A trend towards office-based procedures is observed.
• Current treatments, including surgical and adjuvant medical therapies, yield variable responses.

Conclusions:

• Effective management of recurrent respiratory papillomatosis remains a clinical challenge.
• Adjuvant therapies show mixed efficacy.
• Targeted therapies and vaccines represent promising future directions for RRP management.